Breast cancer is the most common cancer and the second leading cause of death in women.

Despite advances in adjuvant treatment in early stages of the disease, many women will relapse, often not susceptible of a complete surgical excision.

Several studies show that early breast cancer detection reduces the mortality, although remains above 20% at 5 years. The capabilities to define the disease extension, to assess of treatment and to predict tumour behaviour in breast cancer patients, are critical factors in order to achieve better results.

MAMMI is the PET system with highest resolution and sensitivity in the market, specifically dedicated to breast cancer detection in early stages and its assessment in later phases.

This system uses gamma ray detectors based on an innovative design and the latest generation of photosensors and scintillation crystals. Its unique detection principle does not require breast compression to obtain high quality and resolution images. The studies are carried out with the woman lying down in prone position, following the best protocols established for whole body PET scanners in order to clinically validate the system. The obtained 3D images are highly accurate quantified (SUV). A comfortable bed allows the patient to be properly positioned for an optimal scanning.

MAMMI is being developed in close collaboration with leading centers of Europe, in the European framework program, "Combating Cancer".